Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02374645
Recruitment Status : Completed
First Posted : March 2, 2015
Last Update Posted : April 24, 2020
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Hutchison Medipharma Limited